Clinical Trials Sponsored by Max Planck Research Unit for Neurogenetics

Total 11 results

Max Planck Institute for Metabolism Research
Yale University

Completed

Effect of High-fat/High-sugar Diet on Food Reward Signaling

Behavior, Eating
Universitaire Ziekenhuizen KU Leuven
Hospital Clinic of Barcelona; Universitair Ziekenhuis Brussel; Max Planck Research... and other collaborators

Recruiting

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 (ANOSMIC-19)

SARS-CoV-2

Belgium
Central Institute of Mental Health, Mannheim
Max Planck Institute for Metabolism Research

Unknown

Evaluation Study of New Compounds With Potential Use in Schizophrenia (EICAS)

Schizophrenia

Germany
Max Planck Institute for Human Cognitive and Brain...
European Research Council

Completed

Plasticity of the Compassionate Brain

Healthy Subjects

Germany
University of Malaya
Michael J. Fox Foundation for Parkinson's Research; University of Dundee; Nextcea... and other collaborators

Unknown

LRRK2 G2385R Leucocyte and Urine Biomarker Study (LRRK2 G2385R)

Parkinson Disease

Malaysia
Max Planck Institute for Human Cognitive and Brain...
Universitätsklinikum Leipzig; DFG - Deutsche Forschungs Gemeinschaft (German... and other collaborators

Recruiting

Impact of Microbiome-changing Interventions on Food Decision-making (MIFOOD)

Overweight and Obesity

Germany
Max-Planck-Institute of Psychiatry
University of Erlangen-Nürnberg Medical School; Institute for Sex Research... and other collaborators

Completed

Observational Study on Metabolism and Psychopathology in Transsexual Patients

Transsexualism

Germany
German Federal Institute for Risk Assessment
University of Vienna; Heidelberg University; University of Jena; University of... and other collaborators

Not yet recruiting

Cohort Study on Plant-based Diets (COPLANT Study) (COPLANT)

Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Bone Loss | Dietary Exposure | Sustainability | Vitamin Deficiency | Mineral Deficiency | Exposure

Germany, Austria
International Cancer Research Group, United Arab...
King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaborators

Recruiting

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. (ICRG0201)

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

Algeria, Jordan, Saudi Arabia
PENTA Foundation
Baylor College of Medicine; University Hospital Birmingham NHS Foundation Trust and other collaborators

Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old (D3 (Penta21))

HIV Infections

Spain, United Kingdom, Thailand, South Africa, Uganda
Hospital Clínico Universitario de Valladolid
Hospital Clinic of Barcelona; Hospital de Basurto; Complejo Hospitalario de Navarra and other collaborators

Recruiting

Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis (PIPPAS)

Periprosthetic Fractures | Periprosthetic Fracture of the Upper or Lower Limb | Peri-implant Fracture of the Upper or Lower Limb | Peri-implant Fracture

Spain

Clinical Trials Sponsored by Max Planck Research Unit for Neurogenetics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations